{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:25:36Z","timestamp":1787761536371,"version":"build-2784847793"},"reference-count":18,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.schres.2011.05.018","type":"journal-article","created":{"date-parts":[[2011,6,27]],"date-time":"2011-06-27T23:58:42Z","timestamp":1309219122000},"page":"75-81","source":"Crossref","is-referenced-by-count":79,"title":["Efficacy of iloperidone in schizophrenia: A PANSS five-factor analysis"],"prefix":"10.1016","volume":"131","author":[{"given":"Leslie","family":"Citrome","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyi","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marla","family":"Hochfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.schres.2011.05.018_bb0005","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/j.1742-1241.2009.02142.x","article-title":"Iloperidone for schizophrenia: A review of the efficacy and safety profile for this newly-commercialised second-generation antipsychotic","volume":"63","author":"Citrome","year":"2009","journal-title":"Int. J. Clin. Pract."},{"issue":"6","key":"10.1016\/j.schres.2011.05.018_bb0010","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1742-1241.2010.02344.x","article-title":"Iloperidone redux: a dissection of the Drug Approval Package for this newly commercialised second-generation antipsychotic","volume":"64","author":"Citrome","year":"2010","journal-title":"Int. J. Clin. Pract."},{"issue":"2 Suppl 1","key":"10.1016\/j.schres.2011.05.018_bb0015","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1097\/JCP.0b013e318169d4ce","article-title":"Four-week, double-blind, placebo- and ziprasidone-controlled trial of iloperidone in patients with acute exacerbations of schizophrenia","volume":"28","author":"Cutler","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"issue":"2 Suppl 1","key":"10.1016\/j.schres.2011.05.018_bb0020","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1097\/JCP.0b013e318169cca7","article-title":"Long-term efficacy and safety of iloperidone: results from 3 clinical trials for the treatment of schizophrenia","volume":"28","author":"Kane","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.schres.2011.05.018_bb0025","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/JCP.0b013e3181d35d6b","article-title":"Efficacy and safety of asenapine in a placebo- and haloperidol-controlled trial in patients with acute exacerbation of schizophrenia","volume":"30","author":"Kane","year":"2010","journal-title":"J. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.schres.2011.05.018_bb0030","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2165\/11587630-000000000-00000","article-title":"Schizoaffective disorder, a review of current research themes and pharmacologic management","volume":"25","author":"Kantrowitz","year":"2011","journal-title":"CNS Drugs"},{"issue":"2","key":"10.1016\/j.schres.2011.05.018_bb0035","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"issue":"5","key":"10.1016\/j.schres.2011.05.018_bb0040","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1600-0447.1998.tb10101.x","article-title":"Factorial structure of the Positive and Negative Syndrome Scale (PANSS): a forced five-dimensional factor analysis","volume":"98","author":"Lan\u00e7on","year":"1998","journal-title":"Acta Psychiatr. Scand."},{"issue":"2","key":"10.1016\/j.schres.2011.05.018_bb0045","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3371\/CSRP.3.2.5","article-title":"The Five-Factor Structure of the PANSS: A Critical Review of its Consistency Across Studies","volume":"3","author":"Lehoux","year":"2009","journal-title":"Clin. Schizophr. Relat. Psychoses"},{"issue":"5","key":"10.1016\/j.schres.2011.05.018_bb0050","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/jcp\/.0b013e31814cfabd","article-title":"Revisiting the 5 dimensions of the Positive and Negative Syndrome Scale","volume":"27","author":"Levine","year":"2007","journal-title":"J. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.schres.2011.05.018_bb0055","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/BF02354306","article-title":"A newfive factor model of schizophrenia","volume":"65","author":"Lindenmayer","year":"1994","journal-title":"Psychiatr. Q."},{"issue":"4","key":"10.1016\/j.schres.2011.05.018_bb0060","doi-asserted-by":"crossref","first-page":"551","DOI":"10.4088\/JCP.v65n0416","article-title":"Effects of Atypical Antipsychotics on the Syndromal Profile in Treatment-Resistant Schizophrenia","volume":"65","author":"Lindenmayer","year":"2004","journal-title":"J. Clin. Psychiatry"},{"issue":"12","key":"10.1016\/j.schres.2011.05.018_bb0065","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4088\/JCP.v58n1205","article-title":"The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials","volume":"58","author":"Marder","year":"1997","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2011.05.018_bb0085","author":"Novartis Pharmaceuticals Corporation"},{"issue":"3","key":"10.1016\/j.schres.2011.05.018_bb0070","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/01.yic.0000182121.59296.70","article-title":"Ziprasidone and amisulpride effectively treat negative symptoms: results of a 12-week, double-blind study","volume":"21","author":"Olie","year":"2006","journal-title":"Int. Clin. Psychopharamacol."},{"issue":"2 Suppl 1","key":"10.1016\/j.schres.2011.05.018_bb0075","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1097\/JCP.0b013e3181692787","article-title":"Efficacy of iloperidone in the treatment of schizophrenia: initial phase 3 studies","volume":"28","author":"Potkin","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"issue":"2\u20133","key":"10.1016\/j.schres.2011.05.018_bb0080","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.schres.2005.09.002","article-title":"Factor structure and external validity of the PANSS revisited","volume":"82","author":"Van den Oord","year":"2006","journal-title":"Schizophr. Res."},{"issue":"5","key":"10.1016\/j.schres.2011.05.018_bb0090","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000285058","article-title":"Empirical assessment of the factorial structure of clinical in schizophrenia.A multisite, multimodel evaluation of the factorial structure of the Positive and Negative Syndrome Scale. The PANSS Study Group","volume":"30","author":"White","year":"1997","journal-title":"Psychopathology"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996411002945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996411002945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T20:53:53Z","timestamp":1543697633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996411002945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":18,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0920996411002945"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2011.05.018","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}